SCHEMBL22969403

SCHEMBL22969403

Nc1ccc(-c2cccc3c2OCC3)c(N)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.43
HASPIN Q8TF76 1/20 0.36
MAP4K1 Q92918 1/20 0.36
DYRK1A Q13627 2/20 0.34
GRM2 Q14416 1/20 0.34
PIK3CA P42336 2/20 0.32
AKT1 P31749 1/20 0.32
MTOR P42345 1/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
HCRTR1 O43613 2/20 0.31
HCRTR2 O43614 2/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
NOS3 P29474 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29495954 1.00 PARP1 (0.43) PARP1HASPINMAP4K1DYRK1AGRM2
SCHEMBL29495812 0.91 PARP1 (0.35) PARP1HASPINMAP4K1NOS3
SCHEMBL22969433 0.91 PARP1 (0.35) PARP1HASPINMAP4K1NOS3
SCHEMBL22969620 0.80 CHEK2 (0.43) MAP4K1CHEK2
SCHEMBL29495802 0.80 CHEK2 (0.43) MAP4K1CHEK2
SCHEMBL24671043 0.77 NOS3 (0.35) PARP1HASPINHCRTR1HCRTR2GRIN2D
SCHEMBL22969570 0.75 CDK2 (0.36) PARP1HASPINNOS3
SCHEMBL29495957 0.75 CDK2 (0.36) PARP1HASPINNOS3
SCHEMBL29496081 0.74 CDK2 (0.35) PARP1HASPINMAP4K1GRIN2DGRIN3B
SCHEMBL3392361 0.70 PARP1 (0.40) PARP1HASPINMAP4K1DYRK1AGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269730-A 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists 多曼治疗学公司 2022-04-01 CN claimed
US-20220298135-A1 5-HETEROARYL-PYRIDIN-2-AMINE COMPOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS DOMAIN THERAPEUTICS (FR) 2022-09-22 US disclosed
CN-114269730-A 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists 多曼治疗学公司 2022-04-01 CN disclosed
WO-2021023813-A1 5-HETEROARYL-PYRIDIN-2-AMINE CONFOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS DOMAIN THERAPEUTICS (FR) 2021-02-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220298135-A1 5-HETEROARYL-PYRIDIN-2-AMINE COMPOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS NPFFR2, NPFFR1, OPRL1 PARP1 3040/4885HASPIN 1831/4885MAP4K1 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.